FDA Approves ARTHRITIS PAIN RELIEVER — Publix Super Markets Inc

Publix Super Markets Inc’s FDA approval of its diclofenac sodium topical preparation on May 16, 2019, further expands the generic threat to big-name brand arthritis treatments, pressing manufacturers to evaluate accelerated discounts to protect their market share in the nonsteroidal anti-inflammatory drug space.